Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-26 @ 12:29 AM
NCT ID:
NCT03849560
Group ID:
EG000
Title:
Grippol® Quadri
Description:
Grippol® Quadri, a quadrivalent inactivated subunit influenza vaccine. Dosage form: suspension for intramuscular and subcutaneous injection. Dosage: 0.5 ml (1 dose)
Active ingredients:
* type A (H1N1) influenza virus antigen 5 µg;
* type A (H3N2) influenza virus antigen 5 µg;
* type B (Yamagata lineage) influenza virus antigen 5 µg;
* type B (Victoria lineage) influenza virus antigen 5 µg;
* immunoadjuvant Polyoxidonium® (azoximer bromide) 500 µg.
Grippol® Quadri: Single intramuscular injection of 0.5 ml (1 dose) of vaccine Grippol® Quadri into the upper third of the outer surface of the shoulder (the deltoid muscle).
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
205
Other Number Affected:
90
Other Number At Risk:
205
Study:
NCT03849560
Results Section:
NCT03849560
Adverse Events Module:
NCT03849560